Tom Koenig
Executive Director, Biosimilar Market Access
Boehringer Ingelheim
Tom Koenig is the executive director, biosimilar market access at Boehringer Ingelheim. He is responsible for the commercial development and implementation of market access strategies for biosimilar candidates. Tom has had a diverse background that includes leadership roles in market access, account management, payer marketing and sales management during his 20-plus year career. Previously, Tom served as senior director of payer and market access strategy at Biogen where he was responsible for market access strategies in support of the launch of two new hemophilia therapeutics and Alzheimer’s disease pipeline products.
